Kenya
· Delayed Price · Currency is KES Car & General (Kenya) Statistics
Total Valuation
NASE:CGEN has a market cap or net worth of KES 1.76 billion. The enterprise value is 9.50 billion.
| Market Cap | 1.76B |
| Enterprise Value | 9.50B |
Important Dates
The last earnings date was Friday, May 30, 2025.
| Earnings Date | May 30, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
NASE:CGEN has 80.21 million shares outstanding.
| Current Share Class | 80.21M |
| Shares Outstanding | 80.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 11.15% |
| Owned by Institutions (%) | n/a |
| Float | 10.33M |
Valuation Ratios
The trailing PE ratio is 3.39.
| PE Ratio | 3.39 |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.32 |
| P/FCF Ratio | 1.63 |
| P/OCF Ratio | 1.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.12, with an EV/FCF ratio of 8.84.
| EV / Earnings | 18.33 |
| EV / Sales | 0.45 |
| EV / EBITDA | 8.12 |
| EV / EBIT | 11.68 |
| EV / FCF | 8.84 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 1.34.
| Current Ratio | 0.97 |
| Quick Ratio | 0.31 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | 8.20 |
| Debt / FCF | 7.25 |
| Interest Coverage | 0.50 |
Financial Efficiency
Return on equity (ROE) is 9.11% and return on invested capital (ROIC) is 2.58%.
| Return on Equity (ROE) | 9.11% |
| Return on Assets (ROA) | 1.85% |
| Return on Invested Capital (ROIC) | 2.58% |
| Return on Capital Employed (ROCE) | 7.26% |
| Revenue Per Employee | 5.74M |
| Profits Per Employee | 142,036 |
| Employee Count | 3,649 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, NASE:CGEN has paid 255.24 million in taxes.
| Income Tax | 255.24M |
| Effective Tax Rate | 32.67% |
Stock Price Statistics
The stock price has decreased by -12.00% in the last 52 weeks. The beta is -0.65, so NASE:CGEN's price volatility has been lower than the market average.
| Beta (5Y) | -0.65 |
| 52-Week Price Change | -12.00% |
| 50-Day Moving Average | 22.06 |
| 200-Day Moving Average | 22.80 |
| Relative Strength Index (RSI) | 51.89 |
| Average Volume (20 Days) | 1,080 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NASE:CGEN had revenue of KES 20.94 billion and earned 518.29 million in profits. Earnings per share was 6.46.
| Revenue | 20.94B |
| Gross Profit | 3.21B |
| Operating Income | 593.62M |
| Pretax Income | 781.29M |
| Net Income | 518.29M |
| EBITDA | 801.89M |
| EBIT | 593.62M |
| Earnings Per Share (EPS) | 6.46 |
Balance Sheet
The company has 317.97 million in cash and 7.80 billion in debt, giving a net cash position of -7.48 billion or -93.26 per share.
| Cash & Cash Equivalents | 317.97M |
| Total Debt | 7.80B |
| Net Cash | -7.48B |
| Net Cash Per Share | -93.26 |
| Equity (Book Value) | 5.81B |
| Book Value Per Share | 69.17 |
| Working Capital | -358.61M |
Cash Flow
In the last 12 months, operating cash flow was 1.41 billion and capital expenditures -334.98 million, giving a free cash flow of 1.08 billion.
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -334.98M |
| Free Cash Flow | 1.08B |
| FCF Per Share | 13.41 |
Margins
Gross margin is 15.33%, with operating and profit margins of 2.83% and 2.47%.
| Gross Margin | 15.33% |
| Operating Margin | 2.83% |
| Pretax Margin | 3.73% |
| Profit Margin | 2.47% |
| EBITDA Margin | 3.83% |
| EBIT Margin | 2.83% |
| FCF Margin | 5.13% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.65%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.65% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.64% |
| Earnings Yield | 29.51% |
| FCF Yield | 61.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 25, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Mar 25, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NASE:CGEN has an Altman Z-Score of 1.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 5 |